News | Remote Monitoring | February 19, 2019

Ochsner Health System Implementing New Cardiac Device Monitoring Platform

Louisiana-based health system will use Geneva Health Solutions’ cloud-based platform to monitor patient cardiac devices in five-state region

Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices.

Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices. 


February 19, 2019 — Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable cardiac devices. This partnership marks the first time the GHS cloud-based technology platform and remote monitoring service for patients with cardiac implants will be utilized in the region, which includes Louisiana, Arkansas, Mississippi, Alabama and Georgia. The GHS system will drive full automated scheduling and reporting in collaboration with Ochsner’s established Epic electronic medical record (EMR).

Todd Mule, vice president, cardiology service line, Ochsner Health System, said, “Ochsner is committed to investing in patient-centric technology and are confident that partnering with Geneva Health Solutions will further enhance what we are able to offer our patient and coordinated care team through our electronic medical records platform, Epic. Ochsner’s investment in and enthusiasm for technology offers our patients enhanced coordination of care, convenience and better results.”

Millions of Americans have implanted cardiac devices. Patients with these devices — such as pacemakers, defibrillators and loop recorders — transmit critical cardiac data from their implanted device from the comfort of their homes to the provider via the cloud. These transmissions allow providers to monitor their patients proactively for both routine device follow-up and alerts regarding device issues or clinical events, like atrial fibrillation and other indicators of heart failure. The GHS patent-pending platform aggregates cardiac device data from all major device manufacturers’ remote monitoring portal, in-office checks and ER visits. The GHS remote monitoring service helps providers manage the incoming data in an outpatient setting.

For more information: www.genevahealthsolutions.com


Related Content

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
Subscribe Now